These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 18238944)
1. Fenfluramine: riddle or Rosetta stone? Weir EK; Obreztchikova M; Hong Z Eur Respir J; 2008 Feb; 31(2):232-5. PubMed ID: 18238944 [No Abstract] [Full Text] [Related]
2. Fluoxetine is a safer alternative to fenfluramine in the medical treatment of obesity. Anchors M Arch Intern Med; 1997 Jun; 157(11):1270. PubMed ID: 9183245 [No Abstract] [Full Text] [Related]
3. [Valvular heart disease and primary pulmonary hypertension associated with fenfluramine-phentermine]. Wolf I; Mouallem M; Farfel Z Harefuah; 1998 Dec; 135(11):515-7. PubMed ID: 10911468 [No Abstract] [Full Text] [Related]
11. [Drug-clinics. The hue and cry over central appetite suppressants!]. Scheen AJ Rev Med Liege; 1997 Sep; 52(9):613-5. PubMed ID: 9441348 [No Abstract] [Full Text] [Related]
12. Pulmonary hypertension as a result of drug therapy. Higenbottam T; Laude L; Emery C; Essener M Clin Chest Med; 2004 Mar; 25(1):123-31. PubMed ID: 15062604 [TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy for obesity -- do the benefits outweigh the risks? Manson JE; Faich GA N Engl J Med; 1996 Aug; 335(9):659-60. PubMed ID: 8687523 [No Abstract] [Full Text] [Related]
14. Dexfenfluramine. An updated review of its therapeutic use in the management of obesity. Davis R; Faulds D Drugs; 1996 Nov; 52(5):696-724. PubMed ID: 9118819 [TBL] [Abstract][Full Text] [Related]
15. The treatment of obesity with drugs. Hirsch J Am J Clin Nutr; 1998 Jan; 67(1):2-4. PubMed ID: 9440366 [No Abstract] [Full Text] [Related]